Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • HCV Protease
    (1)
  • Others
    (11)
Filter
Search Result
Results for "

amlodipine besilate impurity f

" in TargetMol Product Catalog
  • Inhibitor Products
    13
    TargetMol | Activity
  • Peptides Products
    1
    TargetMol | inventory
Amlodipine besilate impurity F
T29998140171-66-0
Amlodipine besilate impurity F, also known as Amlodipine Dimethyl Ester, is a biochemical.
  • $310
Backorder
Size
QTY
Amlodipine besilate impurity G
T2099443067-01-2
Amlodipine besilate impurity G is a Calcium Channel antagonist with potential application in the study of neurological diseases and is an impurity in the synthesis of Amlodipine besilate.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Sofosbuvir impurity F
T129611337482-17-3
Sofosbuvir impurity F (Sofosbuvir 3',5'-Bis-(S)-phosphate) is both a diastereomer of Sofosbuvir and an impurity of Sofosbuvir which is an inhibitor of HCV RNA replication.
  • $747
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Abacavir Impurity F
T64644
9-((1R,4S)-4-(tert-Butoxymethyl)cyclopent-2-en-1-yl)-N6-cyclopropyl-9H-purine-2,6-diamine is a useful organic compound for research related to life sciences and the catalog number is T64644.
    7-10 days
    Inquiry
    Amlodipine besilate impurity B
    T20997721958-72-1
    Amlodipine besilate impurity B is a biochemical.
    • $287
    Backorder
    Size
    QTY
    Amlodipine besilate impurity E
    T20996140171-65-9
    Amlodipine besilate impurity E is a biochemical.
    • $259
    Backorder
    Size
    QTY
    Loratadine specified impurity F
    T20814125743-80-8
    Loratadine specified impurity F is a fluorinated analog of Loratadine.
    • $413
    Backorder
    Size
    QTY
    Impurity F of Calcipotriol
    T11646112875-61-3
    Impurity F of Calcipotriol is a impurity of Calcipotriol. Calcipotriol (MC 903; Calcipotriene) is a ligand of VDR-like receptors.
    • $812
    Backorder
    Size
    QTY
    Amlodipine aspartic acid impurity
    TP1234400602-35-9
    Amlodipine aspartic acid is a calcium channel blocker compound that exhibits antihypertensive and antianginal properties. It is important to note that Amlodipine aspartic acid impurity is an impurity specific to this compound.
    • Inquiry Price
    Size
    QTY
    Fexofenadine Impurity F
    T73972185066-33-5
    Fexofenadine Impurity F, an impurity present in Fexofenadine, is characterized by its role in the pharmacological profile of this drug. As a H1R antagonist, Fexofenadine serves as an anti-allergic agent, effectively employed in the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria [1].
    • Inquiry Price
    Size
    QTY
    Amlodipine besilate impurity D
    T20995113994-41-5
    Amlodipine besilate impurity D is a biochemical.
    • $310
    Backorder
    Size
    QTY
    Hydroxychloroquine Impurity F
    T739646281-58-9
    Hydroxychloroquine Impurity F, an impurity in Hydroxychloroquine, is identified in the synthetic antimalarial agent known for its capability to inhibit Toll-like receptor 7/9 (TLR7/9) signaling. Additionally, Hydroxychloroquine demonstrates effective inhibition of SARS-CoV-2 infection in vitro [1] [2] [3].
    • Inquiry Price
    Size
    QTY
    Ibuprofen Impurity F
    T4075265322-85-2
    Ibuprofen Impurity F is a known impurity of Ibuprofen, which acts as an anti-inflammatory inhibitor that selectively targets both COX-1 and COX-2 enzymes. It exhibits inhibitory activity with IC50 values of 13 μM and 370 μM for COX-1 and COX-2, respectively.
    • Inquiry Price
    7-10 days
    Size
    QTY